Bank of New York Mellon’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Bank of New York Mellon’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40,489	Closed	-$156K	–	4431
2023 Q2	$156K	Hold	40,489	–	–	﹤0.01%	4030
2023 Q1	$122K	Buy	40,489 +12,757	+46%	+$44.1K	﹤0.01%	4042
2022 Q4	$56.9K	Hold	27,732	–	–	﹤0.01%	4218
2022 Q3	$95K	Buy	27,732 +422	+2%	+$1.92K	﹤0.01%	4209
2022 Q2	$115K	Hold	27,310	–	–	﹤0.01%	4199
2022 Q1	$83K	Hold	27,310	–	–	﹤0.01%	4441
2021 Q4	$127K	Hold	27,310	–	–	﹤0.01%	4369
2021 Q3	$211K	Hold	27,310	–	–	﹤0.01%	4197
2021 Q2	$235K	Buy	27,310 +15,117	+124%	+$133K	﹤0.01%	4047
2021 Q1	$138K	Buy	+12,193	New	+$191K	﹤0.01%	4122

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $875M AUM

Bank of New York Mellon's DBTX Position: Q3 2023 in Review

Bank of New York Mellon sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 40,489 shares — an estimated $156K sold.

Bank of New York Mellon first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $235K in Q2 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Bank of New York Mellon reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of New York Mellon sold 40,489 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $156K.
Bank of New York Mellon first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Bank of New York Mellon's Decibel Therapeutics, Inc. Common Stock position peaked at $235K in Q2 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.